Wells Fargo’s THERAGENICS CORP TGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-1,000
Closed -$2K 6263
2013
Q3
$2K Sell
1,000
-300
-23% -$640 ﹤0.01% 5490
2013
Q2
$3K Buy
+1,300
New +$2.33K ﹤0.01% 5349

Wells Fargo's TGX Position: Q4 2013 in Review

Wells Fargo sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 1,000 shares — an estimated $2K sold.

Wells Fargo first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $3K in Q2 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

  • Wells Fargo reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
  • Wells Fargo sold 1,000 THERAGENICS CORP shares in Q4 2013, an estimated $2K.
  • Wells Fargo first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
  • Wells Fargo's THERAGENICS CORP position peaked at $3K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on Wells Fargo's 13F filing for Q4 2013, filed 6 Feb 2014.